📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

Avanos Medical Inc (AVNS)

NYSE
Currency in USD
Disclaimer
22.39
-0.19(-0.84%)
Closed
After Hours
22.390.00(0.00%)
AVNS Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
22.1822.56
52 wk Range
17.2425.36
Prev. Close
22.39
Open
22.42
Day's Range
22.18-22.56
52 wk Range
17.24-25.36
Volume
140,727
Average Volume (3m)
223,259
1-Year Change
11.84%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
AVNS Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
25.50
Upside
+13.89%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

InvestingPro Research for Avanos Medical Inc


Transformation Journey
Avanos Medical embarks on a three-year plan to enhance efficiency and drive growth, with ambitious targets set for 2025
Financial Resilience
Q2 2024 results surpass expectations, with adjusted EPS of $0.34. Full-year guidance reaffirmed, projecting sales of $685-705 million
Segment Performance
Digestive Health shines with 9% organic growth, while Pain Management faces challenges. Long-term strategy aims to balance portfolio
Market Valuation
Trading at 13x 2025 EPS estimate of $1.80, Avanos' valuation reflects early-stage transformation and growth potential

Avanos Medical Inc Company Profile

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx’s knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Compare AVNS to Peers and Sector

Metrics to compare
AVNS
Peers
Sector
Relationship
P/E Ratio
138.1x−13.0x−0.6x
PEG Ratio
1.14−0.160.00
Price/Book
0.8x2.3x2.6x
Price / LTM Sales
1.4x2.6x3.3x
Upside (Analyst Target)
13.9%47.8%44.5%
Fair Value Upside
Unlock5.2%6.0%Unlock

People Also Watch

101.20
BELFA
+0.91%
50.85
ACIW
+1.34%
38.83
EXLS
+1.07%
229.33
PODD
+0.68%

FAQ

What Is the Avanos Medical (AVNS) Stock Price Today?

The Avanos Medical stock price today is 22.39

What Stock Exchange Does Avanos Medical Trade On?

Avanos Medical is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Avanos Medical?

The stock symbol for Avanos Medical is "AVNS."

What Is the Avanos Medical Market Cap?

As of today, Avanos Medical market cap is 964.65M.

What is Avanos Medical Earnings Per Share?

The Avanos Medical EPS is 0.166.

What Is the Next Avanos Medical Earnings Date?

Avanos Medical will release its next earnings report on Oct 30, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.